BioSig Technologies, Inc. Common StockBSGM
About: BioSig Technologies Inc is a commercial-stage medical device company with an advanced digital signal processing technology platform to deliver insights to the treatment of cardiovascular arrhythmias. Through collaboration with physicians, experts, and healthcare leaders across the field of electrophysiology (EP), It is committed to addressing healthcare's biggest priorities saving time, saving costs, and saving lives. Its first product, the PURE EP System, is an FDA-cleared non-invasive class II device consisting of a unique combination of hardware and software designed to provide unprecedented signal clarity and precision for real-time visualization of intracardiac signals paving the way for personalized patient care.
Employees: 47
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
46.82% more ownership
Funds ownership: 0% [Q3] → 46.82% (+46.82%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for BSGM.
Financial journalist opinion









